Oseltamivir news

All news on Oseltamivir (also known as Tamiflu): plants, production capacities, investments and involved companies.

7 January 2026

Merck Finalizes Cidara Therapeutics Acquisition

Merck acquires Cidara, enhancing its respiratory portfolio with CD388, a long-acting antiviral for influenza prevention, impacting 2026 R&D expenses and EPS.

Who will be producing Oseltamivir in the future?

Find out with chemXplore Alpha

Learn more